STAT+: Pharmalittle: We’re reading about a Novartis heart drug, BIO fighting a Trump program, and more
· statnews.com · popularity 33/100 · 0 similar stories today · Addiction & Behavioral Health (Health & Life Sciences)
Read the original at statnews.com →
Summary
Novartis is largely abandoning a drug once considered a potential blockbuster after a study found it had little promise for preventing heart attacks and deaths
Found in: STAT News. Rating basis: single outlet; outlet tier 4; 1 feeds; feed position 3.